This brand name is authorized in Brazil, Estonia, Finland, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United States
The drug KOSELUGO contains one active pharmaceutical ingredient (API):
1
Selumetinib
UNII 6UH91I579U - SELUMETINIB
|
Selumetinib is a selective inhibitor of mitogen activated protein kinase kinases 1 and 2 (MEK ½). Selumetinib blocks MEK activity and the RAF-MEK-ERK pathway. Therefore, MEK inhibition can block the proliferation and survival of tumour cells in which the RAF-MEK-ERK pathway is activated. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
KOSELUGO Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
KOSELUGO Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L01EE04 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EE Mitogen-activated protein kinase (MEK) inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 502321070034502, 502321070034602 |
Country: EE | Ravimiamet | Identifier(s): 1851476, 1851487 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 058548, 467554 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8774, 8775 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049540014, 049540026 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4299004M1025, 4299004M2021 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1092846, 1092847 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100455271, 100455296 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67762001, W67763001 |
Country: US | FDA, National Drug Code | Identifier(s): 0310-0610, 0310-0625 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.